"Vibe-chemist" uses ChatGPT to design and synthesize an experimental schizophrenia drug in his garage
Polymarket · x · 2026-09-09
According to a Polymarket alert, self-described "vibe-chemist" Douglas Yao used ChatGPT to help design and synthesize an experimental schizophrenia drug in his garage, claiming it showed antipsychotic effects in mice.
The case highlights how AI is lowering the barrier to drug design while raising safety and compliance questions about at-home synthesis.
Related event: Biochemist synthesizes ChatGPT-designed schizophrenia drug in garage lab(4 posts)→
More from AGI Musings
- dunkhippo33 Shares How He Thinks About Raising Kids in the AI Era — kimmonismus · 2026-10-27
- EE-trained AI educator: systems-bottleneck thinking still matters in the AI era — dunkhippo33 · 2026-10-27
- Why Americans pitch better: a lifetime of class presentations, says AI educator — dunkhippo33 · 2026-10-27
- 'Half the sites I try via agents block access' — the anti-bot paradox holding back the agentic economy — XFreeze · 2026-10-27
- Commoditization dilemma: either human labor or GPUs become the commodity — _AustinCalvert_ · 2026-10-27
- Cosmos Institute launches Oxford AI philosophy journal with $10,000 best-paper prize — lawhsw · 2026-10-27